Articles and Blogs

On November 17, 2021, the Drug Enforcement Administration (“DEA”) issued an advanced notice of proposed rulemaking (“ANPR”) with the goal of obtaining further information regarding the practice of telepharmacy. The DEA is seeking input as it considers promulgating new telepharmacy regulatory requirements. Interested stakeholders have until January 18, 2022 at 11:59 PM EST to... READ MORE

The Drug Enforcement Administration (“DEA”) recently released the 2020 edition of the Pharmacist’s Manual, replacing all previous versions. Since 2010, the Pharmacist’s Manual (“Manual”) has aided pharmacies and pharmacists in understanding how to apply requirements under the Federal Controlled Substances Act (“CSA”) and related DEA regulations. As an agency guidance document, the Manual offers... READ MORE

On Wednesday, July 29, 2020, the U.S. Department of Justice Drug Enforcement Administration (“DEA”) proposed a new rule that would require DEA registrants to electronically report “theft or significant loss” of controlled substances within 15 days of discovery of the circumstances requiring the report (“Proposed Rule”). This proposal is notable as currently there is... READ MORE

On October 30, a bipartisan, bicameral group of lawmakers reintroduced the Creating Opportunities Now for Necessary and Effective Care Technologies (“CONNECT”) for Health Act (S. 2741/ H.R. 4932). This legislation is intended to remove roadblocks to telehealth expansion in Medicare by giving providers the freedom to use alternative payment models and incentive programs, reducing... READ MORE